RXQ Compounding Recalls Midazolam Syringes Due to Sterility Concerns
RXQ Compounding LLC is recalling Midazolam 1mg/mL injection syringes because the company cannot assure the product's sterility.
- Product
- MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SYR C-IV, 55 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-55
- Category
- Drug
- Distribution
- Distributed nationwide